Pillar Biosciences Receives Premarket Approval from FDA for its oncoReveal Dx Lung and Colon Cancer Assay
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease
The goal for the project is the identification and optimization of anti-viral compounds.
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Filing for WHO Emergency Use Authorisation this month
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
The transaction is expected to close in the Q4FY22
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
The data should be submitted by August 12th 2021
Subscribe To Our Newsletter & Stay Updated